Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique
2 other identifiers
interventional
9,014
1 country
1
Brief Summary
The goal of this operational research study is to develop, implement and test integrated CCS\&PT and voluntary FP service delivery models to evaluate whether integrated service delivery can optimize uptake and health impact of both services. The study objectives and learning questions are listed below, along with key outcomes that will be measured.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 22, 2020
CompletedFirst Submitted
Initial submission to the registry
April 25, 2022
CompletedFirst Posted
Study publicly available on registry
May 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 2, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 2, 2027
May 22, 2026
May 1, 2026
6.1 years
April 25, 2022
May 19, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Number of women who will undergo Cervical Cancer Screening by HPV testing
through study completion, an average of 1 year
Study Arms (1)
HPV testing of women for cervical cancer screening
EXPERIMENTALWomen enrolled in this study will receive HPV testing for cervical cancer screening. They will be offered self-sampling. And also they will be offered voluntary Family Planning services, as appropriate.
Interventions
Women enrolled in this study will receive HPV testing for cervical cancer screening. They will be offered self-sampling. And also they will be offered voluntary Family Planning services, as appropriate.
Eligibility Criteria
You may qualify if:
- Women 30 - 49 years or all women living with HIV
- Not currently pregnant
- Patients with a cervix (women who have undergone a total hysterectomy with removal of the cervix are not eligible)
- Living in Maputo or Gaza
- Willing and able to provide informed consent for services.
You may not qualify if:
- Physical or mental impairment that inhibits participation in the study
- Pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- M.D. Anderson Cancer Centerlead
- Population Services Internationalcollaborator
- Eduardo Mondlane Universitycollaborator
- William Marsh Rice Universitycollaborator
Study Sites (1)
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kathleen Schmeler, MD
M.D. Anderson Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 25, 2022
First Posted
May 3, 2022
Study Start
December 22, 2020
Primary Completion (Estimated)
February 2, 2027
Study Completion (Estimated)
February 2, 2027
Last Updated
May 22, 2026
Record last verified: 2026-05